Nathalie Baran
Finanzdirektor/CFO bei Minka Therapeutics SA
Profil
Nathalie Baran is currently the Director of Operations & Finance at Minka Therapeutics SA since 2014.
Previously, she worked as a Business Manager at Société d'Economie Mixte Genopole SAEM from 2006 to 2010.
She also held the position of Principal at Hopital Necker-Enfants Malades.
Dr. Baran obtained an MBA from ESCP Europe Campus Paris.
Aktive Positionen von Nathalie Baran
| Unternehmen | Position | Beginn |
|---|---|---|
Minka Therapeutics SA
 Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Finanzdirektor/CFO | 01.09.2010 |
Ehemalige bekannte Positionen von Nathalie Baran
| Unternehmen | Position | Ende |
|---|---|---|
Société d'Economie Mixte Genopole SAEM
 Société d'Economie Mixte Genopole SAEM Real Estate DevelopmentFinance Société d'Economie Mixte Genopole SAEM engages in the development of biotechnologies. It specializes in the research of genomics and genetics. The company was founded in 1998 and is headquartered in Evry, France. | Corporate Officer/Principal | 01.01.2010 |
| Hopital Necker-Enfants Malades | Corporate Officer/Principal | - |
Ausbildung von Nathalie Baran
| ESCP Europe Campus Paris | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Société d'Economie Mixte Genopole SAEM
Société d'Economie Mixte Genopole SAEM Real Estate DevelopmentFinance Société d'Economie Mixte Genopole SAEM engages in the development of biotechnologies. It specializes in the research of genomics and genetics. The company was founded in 1998 and is headquartered in Evry, France. | Finance |
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Health Technology |
| Hopital Necker-Enfants Malades |